Loading...

AGC Inc.

ASGLFPNK
Basic Materials
Chemicals - Specialty
$30.00
$0.00(0.00%)

AGC Inc. (ASGLF) Financial Performance & Income Statement Overview

Review AGC Inc. (ASGLF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
2.39%
2.39%
Operating Income Growth
-2.29%
2.29%
Net Income Growth
-242.93%
242.93%
Operating Cash Flow Growth
34.002%
34.002%
Operating Margin
5.50%
5.50%
Gross Margin
23.66%
23.66%
Net Profit Margin
-11.28%
11.28%
ROE
-7.66%
7.66%
ROIC
2.47%
2.47%

AGC Inc. (ASGLF) Income Statement & Financial Overview

Analyze AGC Inc.’s ASGLF earnings with segmented quarterly and yearly financial statement figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$499.58B$533.38B$519.03B$516.46B
Cost of Revenue$383.03B$406.10B$387.49B$391.39B
Gross Profit$116.56B$127.28B$131.54B$125.06B
Gross Profit Ratio$0.23$0.24$0.25$0.24
R&D Expenses$0.00$61.37B$157.00M$14.90B
SG&A Expenses$91.49B$34.99B$94.86B$78.16B
Operating Expenses$91.49B$95.46B$94.22B$93.06B
Total Costs & Expenses$474.52B$501.56B$482.36B$484.45B
Interest Income$2.83B$2.34B$2.72B$2.92B
Interest Expense$4.11B$3.95B$4.61B$4.29B
Depreciation & Amortization$44.26B$44.49B$45.26B$45.98B
EBITDA$64.56B$75.40B$67.21B-$36.36B
EBITDA Ratio$0.13$0.14$0.13-$0.07
Operating Income$25.07B$31.82B$36.67B$32.00B
Operating Income Ratio$0.05$0.06$0.07$0.06
Other Income/Expenses (Net)-$8.88B-$7.48B-$19.33B-$118.63B
Income Before Tax$16.18B$24.34B$17.35B-$86.63B
Income Before Tax Ratio$0.03$0.05$0.03-$0.17
Income Tax Expense$8.47B$7.85B$5.66B$3.55B
Net Income$6.65B$12.37B$8.09B-$93.54B
Net Income Ratio$0.01$0.02$0.02-$0.18
EPS$31.35$58.35$38.11-$441.20
Diluted EPS$31.29$58.35$38.11-$441.20
Weighted Avg Shares Outstanding$211.98M$211.96M$212.28M$212.02M
Weighted Avg Shares Outstanding (Diluted)$212.37M$211.96M$212.28M$212.02M

The company's financials show resilient growth, with revenue advancing from $516.46B in Q2 2024 to $499.58B in Q1 2025. Gross profit remained healthy with margins at 23% in Q1 2025 compared to 24% in Q2 2024. Operating income hit $25.07B last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $64.56B. Net income dropped to $6.65B, while earnings per share reached $31.35. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;